Assistant Professor of Surgery, Vanderbilt University
General Surgery
Dr. Ingrid M. Meszoely, MD
|
|
Give Review
Dr. Ingrid M. Meszoely practices General Surgery. She went to medical school at Boston University School of Medicine. Boston University School of Medicine is ranked 30 in research and 52 in primary care medicine She has 3 awards "Regional Top Doctor", "Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Ingrid M. Meszoely is also a published MD. She has 28 paper published. The most recent paper is: Aortoiliac occlusive disease and gastrointestinal malignancy: changing therapeutic options. Dr. Ingrid M. Meszoely accepts Medicare payments and is listed with Medicare.gov.
Publications
- Kinome-wide functional screen identifies role of PLK1 in hormone-independent, ER-positive breast cancer.
- DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: Pilot study findings.
- Short preoperative treatment with erlotinib inhibits tumor cell proliferation in hormone receptor-positive breast cancers.
- Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results.
- Breast cancer risk reduction.
- Validation of an algorithm for the nonrigid registration of longitudinal breast MR images using realistic phantoms.
- A nonrigid registration algorithm for longitudinal breast MR images and the analysis of breast tumor response.
- Hypothalamic Na(+)-K(+)-ATPase inhibitor characterized in two-sided liposomes containing pure renal Na(+)-K(+)-ATPase.
- A novel AIF tracking method and comparison of DCE-MRI parameters using individual and population-based AIFs in human breast cancer.
- Motion correction in diffusion-weighted MRI of the breast at 3T.
- Evaluation of biological agents targeted at early-stage disease.
- Autofluorescence and diffuse reflectance spectroscopy and spectral imaging for breast surgical margin analysis.
- Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation.
- Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates.
- Preoperative chemoradiation therapy for adenocarcinoma of the pancreas: The Fox Chase Cancer Center experience, 1986-2003.
- Undetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with resectable pancreatic adenocarcinoma.
- Peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreas.
- Is reporting of recurrence data important in pancreatic cancer?
- Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis.
- Developmental aspects of early pancreatic cancer.
- p53-dependent acinar cell apoptosis triggers epithelial proliferation in duct-ligated murine pancreas.
- K-Ras-independent effects of the farnesyl transferase inhibitor L-744,832 on cyclin B1/Cdc2 kinase activity, G2/M cell cycle progression and apoptosis in human pancrea...
- Expansion of Pdx1-expressing pancreatic epithelium and islet neogenesis in transgenic mice overexpressing transforming growth factor alpha.
- Nonoperative management of primary colorectal cancer in patients with stage IV disease.
- New trends in gastrointestinal surgical oncology.
- Aortoiliac occlusive disease and gastrointestinal malignancy: changing therapeutic options.
- Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013.
Schools
Boston University School Of Medicine
Vanderbilt University Med Center
Procedures Preformed
- Biopsy of Breast
- Breast Reconstruction
- Excision of Breast Tumor
- Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer
- View All
Doctors Specialties
- Surgical Oncology
- General Surgery
Accepted Insurances
Awards
- Regional Top Doctor
- Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
Vanderbilt University -
University of Southern California - LAC+USC Medical Center -
Boston University School of Medicine
Hospital
-
Vanderbilt Hospital and Clinics
Drug Facts
| NPI NUMBER | 1225120645 | |
| NPPES Provider LastName | MESZOELY | |
| NPPES Provider FirstName | INGRID | |
| NPPES Provider ZIPCode | 372320001 | |
| NPPES Provider State | TN | |
| Specialty Description | Surgical Oncology | |
| Total Claim Count | 18.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1225120645 |
| Last Name Of The Provider | MESZOELY |
| First Name Of The Provider | INGRID |
| View All |
Similar Doctors
|
Dr. Carmen C. Solorzano, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Joseph M. Crane, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Alexander A. Parikh, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Kamran Idrees, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Addison May, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pat W. Whitworth Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John Wright, MD |
|
Dr. Naira Baregamian, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ana M. Grau, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Thomas J. Gianis II, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rondi M. Kauffmann, MD |
|
|
Dr. Carolina Pinzon-Guzman, MD |